Delivery Order SPE2DE21D7010-SPE2D625F21QV

Award Date 1/10/25
Potential Completion Date 1/31/25
Potential Value $2.9K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Delivery Order under a Fixed Price with Economic Price Adjustment pricing type, with a period of performance through February 10, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract, valued at $4,105.38, is for the supply of OSTEOCEL PRO, a specialized spinal implant product. The award is not associated with any set-aside designation, indicating Nuvasive, Inc. competed for the contract in the open market. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone...
This federal contract award was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division. The $17,902.10 fixed-price delivery order contract is for the delivery of specialized spinal medical products and technologies, including spinal fusion devices, rods, screws, cages, interbody implants, and bone graft materials. The contract does not have a set-aside designation, indicating Nuvasive...
This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price and economic price adjustment pricing type, and has an ultimate completion date of May 23, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized spinal medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division. The $16,854.00 fixed-price delivery order with economic price adjustment is for the delivery of specialized spinal medical devices and technologies, including spinal fusion devices, rods, screws, cages, interbody implants, bone graft materials, and surgical instruments. Nuvasive has established itself as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The award, valued at $12,732.72, is a delivery order under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Nuvasive is providing the DLA's Medical Supply Chain with OSTEOCEL PRO, a spinal implant product, to support orthopedic, neurological, and reconstructive surgeries at Department of Defense (DoD)...
This federal contract award, valued at $1,956.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment mechanism, with an ultimate completion date of May 14, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, has established itself as a key supplier of...
This federal contract award, valued at $4,974.92, was made by the Defense Logistics Agency (DLA) to the prime contractor Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The award is a delivery order against an existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, will provide a range of spinal implants, instruments, biologics, and related...
This federal contract award, valued at $2,860.94, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to the prime contractor Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a delivery order for the product "OSTEOCEL PRO" and has a fixed price with economic price adjustment pricing type. The ultimate completion date is March 5, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone...
This federal contract award, valued at $18,454.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order under a larger Blanket Purchase Agreement (BPA) valued at $8 million that Nuvasive holds with the Defense Health Agency (DHA). This BPA serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, allowing DHA and Department of...
  • SPE2DE21D7010
    Indefinite Delivery Contract
  • SPE2DE21D7010-SPE2D625F21QV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The award, valued at $2,860.94, is for the delivery of OSTEOCEL PRO, a spinal implant product. This is a fixed-price with economic price adjustment contract with a period of performance ending on January 31, 2025.

Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the parent company also holds federal contracts for providing a range of specialized spinal medical devices and surgical instruments to the Department of Veterans Affairs (VA) and Department of Defense (DoD) healthcare systems. This contract does not have a set-aside designation, indicating Nuvasive competed openly for the award. The contract is supported by an $8 million Blanket Purchase Agreement (BPA) that Transplant Technology Inc. holds with the Defense Health Agency, which serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle for streamlined ordering of the company's spinal medical products.

Generated 4/11/25, 11:20 AM